drugset / Trial / NCT03780907

Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy

NCT03780907

Phase 2 Completed 18 enrolled Eisai Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this study were to assess the tolerability and safety of E2007 in patients with refractory partial or generalised seizures and to assess the pharmacokinetics of E2007 in epileptic patients receiving at least one concomitant anti-epileptic drug.

Timeline

Start
2003-02-14
Primary completion
2003-08-06
Completion
2003-08-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Perampanel Small molecule 1 mg Oral
Subject Perampanel Small molecule 2 mg Oral

Indications